[HTML][HTML] Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo …
Y Zhang, G Zeng, H Pan, C Li, Y Hu, K Chu… - The Lancet infectious …, 2021 - thelancet.com
Background With the unprecedented morbidity and mortality associated with the COVID-19
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac (…
pandemic, a vaccine against COVID-19 is urgently needed. We investigated CoronaVac (…
[HTML][HTML] Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single …
…, L Wang, Z Wu, D Jiang, X Deng, K Chu… - The Lancet Infectious …, 2022 - thelancet.com
Background Large-scale vaccination against COVID-19 is being implemented in many
countries with CoronaVac, an inactivated vaccine. We aimed to assess the immune persistence …
countries with CoronaVac, an inactivated vaccine. We aimed to assess the immune persistence …
Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo …
…, JX Li, XL Li, QY Mao, H Tao, YT Zhang, X Yao, K Chu… - The Lancet, 2013 - thelancet.com
Background A vaccine for enterovirus 71 (EV71) is needed to address the high burden of
disease associated with infection. We assessed the efficacy, safety, immunogenicity, antibody …
disease associated with infection. We assessed the efficacy, safety, immunogenicity, antibody …
Engaging Asian students through game mechanics: Findings from two experiment studies
There is an increasing interest in using game mechanics to foster user engagement in many
real-world contexts. Many previous studies, however, focused on investigating user …
real-world contexts. Many previous studies, however, focused on investigating user …
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled …
F Zhu, C Zhuang, K Chu, L Zhang, H Zhao… - The Lancet …, 2022 - thelancet.com
Background All currently available SARS-CoV-2 vaccines are administered by
intramuscular injection. We aimed to evaluate the safety and immunogenicity of a live-attenuated …
intramuscular injection. We aimed to evaluate the safety and immunogenicity of a live-attenuated …
Decentralized control of high-speed vehicular strings
K Chu - Transportation science, 1974 - pubsonline.informs.org
The automatic control of a string of high-speed, densely-packed vehicles is studied in a unified
approach. Various input structures for the control schemes and their stability are studied …
approach. Various input structures for the control schemes and their stability are studied …
AI literacy: Definition, teaching, evaluation and ethical issues
Artificial Intelligence (AI) is at the top of the agenda for education leaders today in educating
the next generation across the globe. However, public understanding of AI technologies and …
the next generation across the globe. However, public understanding of AI technologies and …
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised …
…, JJ Xu, R Tang, JL Zhang, WJ Wang, L Duan, K Chu… - The Lancet, 2015 - thelancet.com
Background Up to now, all tested Ebola virus vaccines have been based on the virus strain
from the Zaire outbreak in 1976. We aimed to assess the safety and immunogenicity of a …
from the Zaire outbreak in 1976. We aimed to assess the safety and immunogenicity of a …
Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine in healthy adults aged 18-59 years: report of the randomized, double-blind, and placebo-controlled …
…, H Pan, C Li, B Kan, Y Hu, H Mao, Q Xin, K Chu… - medrxiv, 2020 - medrxiv.org
BACKGROUND The top priority for the control of COVID-19 pandemic currently is the
development of a vaccine. A phase 2 trial conducted to further evaluate the immunogenicity and …
development of a vaccine. A phase 2 trial conducted to further evaluate the immunogenicity and …
Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia
…, YA Ding, HB Leu, WH Yin, WHH Sheu, KM Chu - The American journal of …, 2004 - Elsevier
Elevated plasma levels of asymmetric dimethylarginine (ADMA) have been associated with
attenuated endothelium-dependent vasodilation in hypercholesterolemic patients. However, …
attenuated endothelium-dependent vasodilation in hypercholesterolemic patients. However, …
